Year: 2014

Date Title
Dec 04, 2014 Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant Outcomes
Dec 01, 2014 Pluristem Granted Patent in Singapore for its 3D Cell Expansion Technology
Nov 25, 2014 Pluristem’s Dr. Ohad Karnieli to Present at Two Upcoming Scientific Conferences
Nov 12, 2014 Pluristem Granted Patents in Australia and New Zealand for Use of Placental Cells in the Treatment of Multiple Indications
Nov 10, 2014 Pluristem CEO Zami Aberman to Present at Two Regenerative Medicine Conferences in London on November 12 and 13, 2014
Oct 27, 2014 Case Western Reserve University to Study Pluristem’s PLX-RAD Cells in Umbilical Cord Blood Transplants for the Treatment of Blood Cancers and Genetic Diseases
Oct 21, 2014 Pluristem Advances its Second Major Cell Therapy Product Line from Development to Large-Scale Manufacturing
Oct 07, 2014 Pluristem Wins Cell Therapy Patent Case in Europe; European Patent Office Confirms Validity of Amended Claims
Sep 16, 2014 Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market
Sep 10, 2014 Pluristem to Deliver Scientific Presentations at 3rd International Placenta Stem Cell Society Meeting
Sep 08, 2014 United Therapeutics Advances to Second Cohort in Phase I Trial of Pluristem’s PLX-PAD Cells for Treatment of Pulmonary Arterial Hypertension
Sep 04, 2014 Pluristem to Present at Financial Conferences in New York City on September 10th and 17th, 2014
Jul 31, 2014 Israel’s Ministry of Health Approves Pluristem’s Commercial-Scale 3D Cell Manufacturing Process Used at Its New Haifa Facility
Jul 22, 2014 Pluristem to Host Investor Breakfast and Webcast on July 23 in New York City
Jul 08, 2014 Pluristem Initiates South Korean Arm of Multinational Phase II Intermittent Claudication Trial
Jun 30, 2014 Pluristem’s Ohad Karnieli to Deliver a Plenary Presentation on Cell Therapy Manufacturing at ISUS 2014 Conference
Jun 25, 2014 Pluristem Selects Rotator Cuff Repair as New Orthopedic Indication
Jun 19, 2014 Pluristem Granted Patent in Russia for Treatment of Inflammatory Bowel Disease Using Placenta-Derived Cells
Jun 16, 2014 Pluristem Receives Patent in India for Cell Therapy Production Methods and Compositions
Jun 10, 2014 Pluristem to Exhibit at BIO International Convention in San Diego on June 23 – 26, 2014
Jun 05, 2014 Pluristem Issues Letter to Shareholders
May 29, 2014 Pluristem Move Forward in the Orthopedic Area with the Support of Key Opinion Leaders
May 27, 2014 Pluristem to Participate in Upcoming Financial Conferences
May 20, 2014 Pluristem Receives Clearance from South Korea to Use PLX Cells Manufactured at its New Facility in its Advances studies
May 12, 2014 Pluristem to Present at World Stem Cells Regenerative Medicine Congress 2014 in London
May 07, 2014 Pluristem to be Added to New TA Tech-Elite Stock Index in Israel
Apr 30, 2014 Pluristem Awarded $4.2 Million Grant by Israeli Government
Apr 28, 2014 Pluristem’s Manufacturing Facility Approved by European Auditors for Phase III Trials
Apr 22, 2014 Pluristem and the Alliance for Regenerative Medicine Advocate for Industry Advancement in Washington D.C.
Apr 16, 2014 Pluristem to Deliver Key Commercialization and Scientific Presentations at International Society for Cellular Therapy Conference 2014
Mar 26, 2014 UK’s Minister for Universities and Science, David Willetts & his Delegation Visit Pluristem Regarding UK-Israel Cooperation on Regenerative Medicine
Mar 25, 2014 Pluristem Scientists to Present a Poster on GvHD & Participate in a Panel Discussion at the BIRAX Regenerative Medicine Conference
Mar 12, 2014 Preclinical Results for Pluristem’s PLX-PAD Cells in Tendon Injury Presented at American Academy of Orthopedic Surgeons’ Annual Meeting
Mar 11, 2014 Pluristem to Present at Barclays and RegenMed Financial Conferences
Mar 07, 2014 Pluristem CEO Zami Aberman to Present on Cell & Gene Therapy Panel Discussion at BIO-Europe Spring 2014
Mar 06, 2014 US FDA Approves Pluristem’s Commercial Scale Cell Manufacturing Process
Feb 20, 2014 Pluristem Submits FDA Orphan Drug Application for Preeclampsia
Feb 18, 2014 Pluristem Receives Key 3D Cell Expansion Patent in Australia
Feb 13, 2014 Pluristem CEO Zami Aberman to Speak on Panel at 9th Annual Stem Cell Summit on February 18, 2014
Feb 11, 2014 Medical Key Opinion Leaders in Preeclampsia Join Pluristem’s Steering Committee
Feb 05, 2014 Pluristem Strengthens Executive Team; Announces Senior Executive Appointments
Feb 03, 2014 U.S. National Institutes of Health to Commence New Study of Pluristem’s PLX Cells for Acute Radiation Syndrome Treatment
Jan 30, 2014 Pluristem Issues Letter to Shareholders
Jan 27, 2014 Pluristem CEO Zami Aberman to Present at Phacilitate Cell & Gene Therapy Forum 2014
Jan 23, 2014 Pluristem’s Cell Manufacturing Facility Marks Major Milestone with German Regulatory Approval of New Scaled-Up 3D Manufacturing Process
Jan 21, 2014 Pluristem’s Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints
Jan 08, 2014 Pluristem Receives Key Placental Cell Therapy Patent in Australia
Jan 06, 2014 Results of Pluristem’s Phase I/II Muscle Injury Trial to be Announced on January 21, 2014